Clinical Mastery in Primary Care
May 4, 2026 - 18:37
Radio and PodcastLive Radio & PodcastsScience & Medicine
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
About This Episode
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes is an episode from Annals On Call Podcast by American College of Physicians. Dr. Centor discusses outcomes in patients with...
Podcast
This episode belongs to Annals On Call Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Aug 18, 2025, 29:55 long, audio available.
Related Episodes
Continue listening to more episodes from Annals On Call Podcast.
Physicians Not Providers
Apr 20, 2026 - 19:07
Managing Inpatient Hyponatremia Part 2
Apr 6, 2026 - 28:22
Managing Outpatient Hyponatremia Part 1
Mar 16, 2026 - 19:42
Alzheimer Disease: A Diagnostic Challenge
Mar 2, 2026 - 21:39
Hyponatremia Correction: How Fast Is Too Fast?
Feb 16, 2026 - 21:28
The Role of Corticosteroids in Severe Pneumonia
Feb 2, 2026 - 20:17
Questions About This Episode
What is Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes about?
Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Where can I listen to Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes?
You can listen to Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes from?
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes is an episode from Annals On Call Podcast by American College of Physicians.
How long is this episode?
This episode is 29:55 long.
When was this episode published?
This episode was published on Aug 18, 2025.
Can I save Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Annals On Call Podcast?
Yes. This page shows related episodes from Annals On Call Podcast when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes?
You can listen to Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes is from Annals On Call Podcast by American College of Physicians.
What are the episode details?
Published Aug 18, 2025 and 29:55 long